针对Trop2向的小分子抑制剂的结构引导发现策略
1Department of Biology Education, Daegu University, 201, Daegudae-ro, Gyeongsan-si, Gyeongsangbuk-do 38453, Republic of Korea.
Bulletin du cancer
|February 10, 2026
概括
向Trophoblast细胞表面抗原2 (Trop2) 的小分子显示出对癌症治疗的希望. 基于结构的策略和先进的查方法是开发下一代Trop2抑制剂的关键.
科学领域:
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 热囊细胞表面抗原2 (Trop2) 在上皮癌中过度表达,导致瘤生长和抵抗.
- 针对Trop2的抗体-药物联合体 (ADC) 显示出成功,但具有毒性和耐药性等局限性.
研究的目的:
- 审查针对Trop2的小分子抑制剂的最新进展.
- 专注于Trop2抑制剂开发的基于结构的策略.
- 探索超越ADCs的新型治疗方式.
主要方法:
- 总结Trop2的致癌信号传递机制 (例如,内膜蛋白解,β-catenin稳定).
- 确定小分子结合的关键结构域 (TY循环,ND-CD脊,酸化位点).
- 检查自然化合物 (例如,Brucine D) 和计算/实验工作流 (对接,CETSA,AI选).
主要成果:
- Trop2的关键结构域被确定为小分子抑制剂的潜在结合口袋.
- 布鲁塞因D作为一个自然Trop2-ICD调节器的案例研究.
- 综合计算和实验方法促进了合理的药物设计.
结论:
- 小分子抑制剂是Trop2向癌症治疗中ADCs的一个有希望的替代品.
- 基于结构的设计,基于片段的发现和人工智能引导的选对于优化Trop2抑制剂至关重要.
- 这些策略为开发下一代Trop2疗法提供了一个框架.
更多相关视频
08:45Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
6.6K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.8K
相关概念视频
Eukaryotic Transcription Inhibitors
11.1K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
Drug Discovery: Overview
11.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.8K
Additional Subnuclear Structures
5.4K
The eukaryotic nucleus is a double membrane-bound organelle that contains nearly all of the cell’s genetic material in the form of chromosomes. It is rightly called the “brain” of the cell as it shoulders the responsibility of responding to various physiological processes, stress, altered metabolic conditions, and other cellular signals.
The nucleus contains many membrane-less subnuclear organelles or nuclear bodies, such as nucleoli, Cajal bodies, speckles,...
The nucleus contains many membrane-less subnuclear organelles or nuclear bodies, such as nucleoli, Cajal bodies, speckles,...
5.4K
Molecules and Compounds
69.4K
Atoms and Molecules
69.4K
Structure of Lipids
99.2K
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic...
99.2K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
